Form 4 Tracker
Roger Jeffs

Director; Director, Chief Executive Officer · 16 filings · Latest: Oct 9, 2026

Axsome Therapeutics, Inc.
Liquidia Corp
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
LQDA
SERENDIPITY BIOPHARMA LLC—May 14, 2026
Proposed Sale
$57.59100,000$5.8M—
LQDA
Roger JeffsDirector, Chief Executive OfficerMay 12, 2026
Sale
$54.0425,000$1.4M1,273,095
LQDA
Roger JeffsDirector, Chief Executive OfficerMay 11, 2026
Sale
$41.5025,000$1.0M1,298,095
LQDA
Roger JeffsDirector, Chief Executive OfficerMay 8, 2026
Sale
$42.1425,000$1.1M1,323,095
LQDA
SERENDIPITY BIOPHARMA LLC—May 8, 2026
Proposed Sale
$42.28100,000$4.2M—
LQDA
Roger JeffsDirector, Chief Executive OfficerMay 7, 2026
Sale
$42.0925,000$1.1M1,348,095
LQDA
Roger JeffsDirector, Chief Executive OfficerMay 6, 2026
Sale
$40.7825,000$1.0M1,373,095
LQDA
Roger JeffsDirector, Chief Executive OfficerMay 5, 2026
Sale
$40.1025,000$1.0M1,398,095
LQDA
SERENDIPITY BIOPHARMA LLC—May 7, 2026
Proposed Sale
$42.1425,000$1.1M—
LQDA
Roger JeffsDirector, Chief Executive OfficerApr 17, 2026
Sale
$40.6018,839$765.0K1,423,095
LQDA
SERENDIPITY BIOPHARMA LLC—Apr 17, 2026
Proposed Sale
$41.4068,839$2.8M—
LQDA
Roger JeffsDirector, Chief Executive OfficerApr 16, 2026
Sale
$40.3125,000$1.0M1,441,934
LQDA
Roger JeffsDirector, Chief Executive OfficerApr 15, 2026
Sale
$40.1425,000$1.0M1,466,934
LQDA
Roger JeffsDirector, Chief Executive OfficerApr 14, 2026
Sale
$40.003,300$132.0K1,491,934
LQDA
SERENDIPITY BIOPHARMA LLC—Apr 16, 2026
Proposed Sale
$40.1225,000$1.0M—
LQDA
SERENDIPITY BIOPHARMA LLC—Apr 15, 2026
Proposed Sale
$38.7124,733$957.4K—
LQDA
Roger JeffsDirector, Chief Executive OfficerApr 10, 2026
Sale
$40.1221,433$859.9K1,495,234
LQDA
Roger JeffsDirector, Chief Executive OfficerApr 13, 2026
Sale
$38.3732,744$1.3M1,137,599
LQDA
Roger JeffsDirector, Chief Executive OfficerApr 10, 2026
Option Exercise
—28,167—1,170,343
LQDA
Roger JeffsDirector, Chief Executive OfficerApr 9, 2026
Sale
$40.1225,000$1.0M1,516,667